Endo, Others Ink $166M Lidoderm Pay-For-Delay Settlements
Direct purchasers of the Lidoderm pain patch asked for preliminary approval in California federal court Tuesday of pay-for-delay class settlements totaling $166 million reached with branded pharmaceutical makers Teikoku and Endo...To view the full article, register now.
Already a subscriber? Click here to view full article